Bayesian dose‐finding designs for combination of molecularly targeted agents assuming partial stochastic ordering-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bayesian dose‐finding designs for combination of molecularly targeted agents assuming partial stochastic ordering

Published:2015-02-28 Issue:5 Volume:34 Page:859-875
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statist. Med.

Author:

Guo Beibei¹,Li Yisheng²^ORCID

Affiliation:

1. Department of Experimental Statistics Louisiana State University Baton Rouge LA 70803 U.S.A.

2. Department of Biostatistics The University of Texas MD Anderson Cancer Center Houston TX 77030 U.S.A

Funder

National Cancer Institute

Stand Up to Cancer Dream Team Translational Research Grant, a program of the Entertainment Industry Foundation

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.6376

Reference35 articles.

1. Early oncology clinical trial design in the era of molecular-targeted agents

2. Added value of molecular targeted agents in oncology

3. Molecular-targeted agents combination therapy for cancer: Developments and potentials

4. Dose-Finding with Two Agents in Phase I Oncology Trials

5. Designs for Single- or Multiple-Agent Phase I Trials

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comb-BOIN12: A Utility-Based Bayesian Optimal Interval Design for Dose Optimization in Cancer Drug-Combination Trials;Statistics in Biopharmaceutical Research;2024-08-28

2. SFU: Surface-Free Utility-Based Design for Dose Optimization in Cancer Drug Combination Trials;Statistics in Biosciences;2024-04-07

3. BOIN-ETC: A Bayesian optimal interval design considering efficacy and toxicity to identify the optimal dose combinations;Statistical Methods in Medical Research;2024-03-06

4. Local continual reassessment methods for dose finding and optimization in drug-combination trials;Statistical Methods in Medical Research;2023-08-18

5. A modular framework for early-phase seamless oncology trials;Clinical Trials;2021-01-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3